To test this hypothesis and to assess whether the protein and mRNA levels for MYC, IRF4 and their downstream targets following drug exposure were consistent with those expected from the IRF4‐MYC auto‐regulatory loop model, we used computational techniques to model the MYC and IRF4 gene and protein network in MM cells. This evidence concerns the gene IRF4 and Miyoshi myopathy.